Plunkett Research Online: Allogene Therapeutics Inc

ALLOGENE THERAPEUTICS INC (ALLO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Allogene Therapeutics Inc is a United States-based clinical stage immuno-oncology company. It is mainly engaged in the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The company is involved in developing a pipeline of multiple all.....



Allogene Therapeutics Inc
Ticker: ALLO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 457-2700
Fax:
Address: 210 East Grand Avenue
South San Francisco, CA 94080 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Biological Product (except Diagnostic) Manufacturing
Drug Development
Clinical Testing
Cancer Therapies
Cell Therapy Manufacturing
Contacts Description
David ChangCEO/Co-Founder/Director/President
Arie BelldegrunChairman of the Board/Co-Founder/Director
See More
Allogene Therapeutics Inc is a United States-based clinical stage immuno-oncology company. It is mainly engaged in the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The company is involved in developing a pipeline of multiple all.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
20222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
UCART19
ALLO-501
ALLO-715
ALLO-501A
ALLO-715
ALLO-316
ALLO-605
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: